Herbas VPB

Print
EN | LT
LT - METHODS FOR REDUCING REMNANT CHOLESTEROL AND OTHER LIPOPROTEIN FRACTIONS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)
EN - METHODS FOR REDUCING REMNANT CHOLESTEROL AND OTHER LIPOPROTEIN FRACTIONS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 39/00
A61K 39/395
A61P 9/10
C07K 16/40
European patent
(11) Number of the document 3003361
(13) Kind of document T
(96) European patent application number 14733889.1
Date of filing the European patent application 2014-05-30
(97) Date of publication of the European application 2016-04-13
(45) Date of publication and mention of the grant of the patent 2019-07-03
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2014/040163
Date 2014-05-30
PCT application publication
(87) Number WO 2014/194168
Date 2014-12-04
Priority applications
(30) Number Date Country code
201361828753 P 2013-05-30 US
201361901705 P 2013-11-08 US
201361919836 P 2013-12-23 US
201461935358 P 2014-02-04 US
201461953959 P 2014-03-17 US
201461991738 P 2014-05-12 US
201414290544 2014-05-29 US
Inventors
(72)
SWERGOLD, Gary, US
SASIELA, William, J., US
PORDY, Robert, C., US
Grantee
(73) Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Title
(54) METHODS FOR REDUCING REMNANT CHOLESTEROL AND OTHER LIPOPROTEIN FRACTIONS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)
  METHODS FOR REDUCING REMNANT CHOLESTEROL AND OTHER LIPOPROTEIN FRACTIONS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)
Last update date 2021-04-30